Cite
HARVARD Citation
Munting, A. et al. (2022). Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital. Clinical microbiology and infection. pp. 558-563. [Online].